Locations
Waltham, MA, USA · San Francisco, CA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Other
founded in
2022
Apogee Therapeutics is a clinical stage biotechnology company focused on developing novel biologics for inflammatory and immunological disorders. Their pipeline includes therapies for conditions such as atopic dermatitis, asthma, and chronic obstructive pulmonary disease, aiming to provide differentiated efficacy and dosing compared to existing treatments. With a commitment to reshaping the standard of care, Apogee leverages advanced antibody engineering to optimize therapeutic properties, addressing unmet medical needs in the largest markets for inflammatory and immune diseases. The company is positioned to make significant impacts in the healthcare landscape with its innovative approach and ongoing clinical studies.
Something looks off?On-site & Remote